United Advisor Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.53M Buy
90,228
+855
+1% +$22.8K 0.31% 84
2025
Q4
$2.23M Buy
89,373
+29,502
+49% +$744K 0.28% 90
2025
Q3
$1.53M Buy
59,871
+44,824
+298% +$1.11M 0.21% 113
2025
Q2
$365K Buy
15,047
+2,794
+23% +$65.2K 0.06% 279
2025
Q1
$310K Sell
12,253
-29,323
-71% -$767K 0.06% 270
2024
Q4
$1.1M Sell
41,576
-3,207
-7% -$87K 0.22% 111
2024
Q3
$1.3M Buy
44,783
+34,976
+357% +$1.02M 0.29% 87
2024
Q2
$274K Buy
+9,807
New +$270K 0.09% 215

Other funds holding PFE

United Advisor Group's PFE Position: Q1 2026 in Review

United Advisor Group increased its Pfizer (PFE) stake by 0.96% in Q1 2026, buying an estimated $22.8K and bringing the position to 90,228 shares worth $2.53M. The position accounts for 0.31% of the portfolio, ranked #84.

United Advisor Group first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • United Advisor Group held 90,228 shares of Pfizer worth $2.53M as of Q1 2026.
  • United Advisor Group bought 855 Pfizer shares in Q1 2026, an estimated $22.8K.
  • Pfizer made up 0.31% of United Advisor Group's portfolio in Q1 2026, its #84 holding.
  • United Advisor Group first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on United Advisor Group's 13F filing for Q1 2026, filed 17 Apr 2026.